Research aarkstore enterprise companion diagnostics in personalized medicine and
•
0 likes•111 views
Recommended
Recommended
More Related Content
More from Neel Terde
More from Neel Terde (20)
Research aarkstore enterprise companion diagnostics in personalized medicine and
- 1. ResearchAarkstore Enterprise Companion Diagnostics in Personalized Medicine and Cancer Therapy Aarkstore announce a new report “ Companion Diagnostics in Personalized Medicine and Cancer Therapy “ through its vast collection of market research report.
- 2. http://www.aarkstore.com/search/viewresults.asp?search=2012&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp?search=Markets&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp?search=Cancer%20&PubId=&pagenum=1 Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic application and clinical outcome of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays a vital part in personalized medicine and has greatly expanded over the past twenty years, expanding by more than 20% annually compared to most other laboratory procedures. Research will continue to produce an increased understanding of disease processes, and diagnostics manufacturers will continue to expand and refine the technology and automation needed for clinical testing. Companion diagnostics, although smaller at present, is one of the fastest growing segments in the in vitro diagnostic (IVD) market. And while the concept of a drug-diagnostic combination is not new, it has only recently started to generate interest with the move of healthcare towards pharmacogenomics. This TriMark Publications report examines the use of companion diagnostics in personalized medicine and cancer therapy. The study provides a qualitative and quantitative review of the industry, including cancer biomarker tests, pharmacogenomics tests, recurrence prediction tests, blood-based technologies, proteomics and regulatory trends. Moreover, this analysis profiles the leading companies that are developing and manufacturing companion diagnostics solutions. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included.
- 4. Breast Cancer Therapies Markets HIV-AIDS Testing Markets Over-the-Counter Diagnostic Products World Markets DNA Sequencing and PCR Markets Medical Imaging Markets Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets Diabetes, Metabolic Syndrome and Cardiovascular Disease Catheter Markets Blood Glucose Testing and Diabetes Management Global Flow Cytometry Market U.S. Glucose Testing Markets High-Growth Diagnostic Testing Markets European Point of Care Diagnostic Testing Markets Disposable Syringe Markets Point of Care Diagnostic Testing World Markets Disposable Medical Supplies Markets Molecular Diagnostics in Infectious Disease Testing
- 5. Medical Imaging Bundle Cancer Vaccines Markets European Medical Imaging Markets Respiratory Therapeutics and Devices Markets Diagnostics Bundle Mammography World Markets India's In Vitro Diagnostic Testing Industry Orthopedics Markets Cell-Based Assays for Drug Discovery Cytology and HPV Testing World Markets Clinical Chemistry Analyzers Clinical Immunoanalyzer Markets Microscopy Markets Automated Microbial Testing Markets Anti-Infective Drugs Markets Plastic Surgery Markets Medical Imaging Bundle Cancer Vaccines Markets European Medical Imaging Markets Respiratory Therapeutics and Devices Markets Diagnostics Bundle Mammography World Markets India's In Vitro Diagnostic Testing Industry Orthopedics Markets